Alpha-1-acid glycoprotein as a marker of inflammatory response during anti-tuberculosis treatment
DOI:
https://doi.org/10.33448/rsd-v9i11.10057Keywords:
Tuberculosis; Acute-Phase Reaction; Therapeutics.Abstract
The objective of the study was to evaluate AGA as a marker of inflammatory response in patients with tuberculosis (TB) during anti-TB treatment and its association with clinical and radiological parameters of the disease. Therefore, patients with TB (n=35) were evaluated, according to the time of anti-TB treatment: T1 (1 and 2 months of treatment) (n=16); T2 (3 and 4 months of treatment) (n=10); T3 (5 and 6 months of treatment) (n=11). To assess the potential of AGA as a marker, PCR was measured as a comparison parameter, measured by the turbidimetry technique. Clinical and radiological data were obtained from medical records. The AGA evaluation showed the average of values within the reference range. The T1 group showed significantly higher levels when compared to patients in the T2 group (p=0.006), with no difference in relation to the T3 group. There was also no difference between groups T2 and T3. The CRP levels at T1 were well above the reference value, a fact not observed in other times of anti-tuberculosis treatment (T2 and T3). There was a difference between T1 and T2 (p=0.01), with no other significant association demonstrated. A positive correlation was observed between CRP and AGA at T1 (ρ=0.8653), T2 (ρ=0.6691) and T3 (ρ=0.9282). There was no association between clinical and radiological parameters and AGA and CRP values. We conclude that AGA is a good marker for monitoring the prognosis of evolution according to the time of anti-tuberculosis treatment, and can be used in the routine of patients with TB.
References
Aguiar, F. J. B., Ferreira-Júnior, M., Sales, M. M., Cruz-Neto, L. M., Fonseca, L. A. M., Sumita, N. M., Duarte, N. J. C., Lichtenstein, A. & Duarte, A. J. S. (2013). Proteína C reativa: aplicações clínicas e propostas para utilização racional. Revista da Associação Médica Brasileira, 59(1), 85-92. https://doi.org/10.1590/S0104-42302013000100016
Brasil. Ministério da Saúde. (2018). Implantação do Plano Nacional pelo Fim da Tuberculose como Problema de Saúde Pública no Brasil: primeiros passos rumo ao alcance das metas. Boletim epidemiológico. 49(11):1-18. Recuperado de: https://portalarquivos2.saude.gov.br/images/pdf/2018/marco/26/2018-009.pdf
Brasil. Ministério da Saúde. (2019). Manual de Recomendações para o Controle da Tuberculose no Brasil / Ministério da Saúde. 364 p. Recuperado de: https://sbpt.org.br/portal/wp-content/uploads/2019/06/manual_recomendacoes_tb_2ed_atualizada_8maio19.pdf
Collares, G. B. & Paulino, U. H. M. (2006). Aplicações Clínicas Atuais da Proteína C Reativa. Revista Minas Gerais. 6, 227-333.
Hochman, B., Nahas, F. X., Oliveira Filho, R. S. de & Ferreira, L. M. (2005). Desenhos de pesquisa. Acta Cirúrgica Brasileira. 20(2), 2-9. https://doi.org/10.1590/S0102-86502005000800002
Martins, C., Gama, A. C. de Castro, Valcarenghi, D. & Batschauer, A. P. de B. (2014). Markers of acute-phase response in the treatment of pulmonary tuberculosis. Jornal Brasileiro de Patologia e Medicina Laboratorial, 50(6), 428-433. https://dx.doi.org/10.5935/1676-2444.20140052
Miranda, P., Gil-Santana, L., Oliveira, M. G., Mesquita, E. D., Silva, E., Rauwerdink, A., Cobelens, F., Oliveira, M. M., Andrade, B. B. & Kritski, A. (2017). Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation. PloS one, 12(4), e0175278. https://doi.org/10.1371/journal.pone.0175278
Muller, B. L. A., Ramalho, D. M. de P., Santos, P. F. G. dos, Mesquita, E. D. D., Kritski, A. L. & Oliveira, M. M. (2013). Marcadores inflamatórios e imunogenéticos e sua relação com tuberculose pulmonar. Jornal Brasileiro de Pneumologia, 39(6), 719-727. https://doi.org/10.1590/S1806-37132013000600011
Pepys, M. B. & Hirschfield, G. M. (2003). C-reactive protein: a critical update. The Journal of clinical investigation, 111(12), 1805–1812. https://doi.org/10.1172/JCI18921
Pereira, A. S., Shitsuka, D. M., Parreira, F. J & Shitsuka, R. (2018). Metodologia da pesquisa científica. Santa Maria, RS: UFSM, NTE.
Peresi, E., Silva, S. M. U. R., Calvi, S. A. & Marcondes-Machado, J. (2008). Cytokines and acute phase serum proteins as markers of inflammatory regression during the treatment of pulmonary tuberculosis. Jornal Brasileiro de Pneumologia, 34(11), 942-949. https://doi.org/10.1590/S1806-37132008001100009
Picheth, G., Bresolin, P. L., Pereira Jr., O., Jaworski, M. C. G, Santos, C. M., Pinto, A. P., Scartezini, M., Alcântara, V. M. & Fadel-Picheth, C. M.T. (2002). Mucoproteína versus alfa-1-glicoproteína ácida: o que quantificar?. Jornal Brasileiro de Patologia e Medicina Laboratorial, 38(2), 87-91. https://dx.doi.org/10.1590/S1676-24442002000200004
Walzl, G., Haks, M. C., Joosten, S. A., Kleynhans, L., Ronacher, K. & Ottenhoff, T. H. (2014). Clinical immunology and multiplex biomarkers of human tuberculosis. Cold Spring Harbor perspectives in medicine, 5(4), a018515. https://doi.org/10.1101/cshperspect.a018515
World Health Organization (WHO). (2019). Global tuberculosis report. Recuperado de: https://www.who.int/tb/publications/global_report/en/.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Priscilla Yukari Ueno; Amanda Aparecida Silva de Aguiar; Ana Carolina Querino de Sousa; Izabelly Geraldes Silva; Christiane Martinez Húngaro; Eliana Peresi-Lordelo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
